Volume : 12, Issue : 06, June – 2025
Title:
METHOD DEVELOPMENT AND VALIDATION OF GLIMEPIRIDE IN PHARMACEUTICAL DOSAGE FORM BY UV VISIBLE SPECTROPHOTOMETRIC METHOD
Authors :
Mrs.K.Srivani*, K.Dharmesh, Mohammad Zameer, Junaid ur Rahman, K.keerthi, Dr.T.Mangilal
Abstract :
Glimiperide is an anti-diabetic drug which is used for the treatment of diabetes. In present work, a simple, sensitive, accurate and economical spectroscopic method has been developed for the estimation of glimepiride in bulk and in pharmaceutical dosage forms.
An absorption maximum was found to be at 249 nm with the solvent system of chloroform. The drug follows Beer’s law limits in the range of 5-30 µg/ml with correlation coefficient of 0.999732. Results of the analysis were validated for accuracy, precision, LOD Were found to be satisfactory. The linearity study for Glimepiride was found in concentration range of 5µg-25µg and correlation coefficient (r) was found to be 0.999 and Regression coefficient (r2)0.999 %Recovery studies were carried out and the percentage recovery was found to be in the range of 100.8% – 101%, %RSD of Absorbance for Intraday, Inter day precision was 1 and 0.95, % RSD for Ruggedness was found to be less than 2. LOD and LOQ of calibration curve of drug prepared in 0.1N NaOH were found to be 0.5and 1.5µg/ml, respectively. The proposed method is simple, rapid and suitable for the routine quality control analysis.
Key words: Glimiperide, Tablets, UV spectrophotometry.
Cite This Article:
Please cite this article in press K.Srivani et al ., Method Development And Validation Of Glimepiride In Pharmaceutical Dosage Form By UV Visible Spectrophotometric Method.., Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1. Klepser T.B., Kelly M.W.; Metformin hydrochloride: An antihyperglycemic agent. Am J Health System Pharm. 1997; 54:893–903.
2. Hitt E.;Uses of metformin may extend beyond patients with type 2 diabetes. Drugs. 1995; 63:1879–94. 3. Maria C.R., Ranetti A.;The pharmacokinetics of some oral antidiabetics –A pharmaceutical approach. Farmacia, 2006; LIV, 6, 3- 13.
4. Hermann L. S.; Metformin:A review of its pharmacological properties and therapeutic use. Diabete metab. 1979; 5(3): 233- 45.
5. Budavari S, in. The Merck Index., ed. Merck and Co Inc., 13thed., 1997; Whitehouse Station (NJ), 5792. 6. Arayne MS, Sultana N, Zuberi MH, Siddiqui FA. Spectrophotometric quantitation of Metformin in bulk drug and pharmaceutical formulations using multivariate technique. Indian J Pharm Sci 2009; 71 (3): 331-335.
7. Chaturvedi PK, Sharma R. Simultaneous spectrophotometric estimation and validation of three component tablet formulation containing pioglitazone hydrochloride, Metformin hydrochloride and Glibenclamide. Analytical Letters 2008; 41(12):2133-2142.
8. Rohokale BS, Jadhav VM, Kadam VJ. Studies in prospective process validation of Metformin HCl tablet Dosage formulation. Int J PharmaTech Res 2010; 2(3):1673-1678.
9. Satoskar RG, Bhandarkar SD, Nirmala N, pharmacology and pharmacotherapeutics, Vol II,17th ed, Popular publication, Mumbai, Maharastra, India.
10. Muller G, Hartz D, Punter J, Okonomopulos R, Kramer W; Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta. 1994; 1191(2):267-77.
11. A. Eswar Kumar, Ch. Niranjan Patra. Formulation Characterization Optimization of Duloxetine loaded Ethosome Patch for Transdermal Application. Research Journal of Pharmacy and Technology 2022; 15(12):5565-0. doi: 10.52711/0974-360X.2022.00940
12. ICH, Q2 (R1) Validation of analytical procedure: Text and methodology, International Conference on Harmonization, Geneva, Switzerland, 2005.
13. Ramadan, Abdul Aziz & Mandil, Hasna & Zeino,. (2016). Spectrophotometric determination and validation of glimepiride in pure and tablet dosage forms through ion-pair complex formation using bromocresol green. International Journal of Pharmacy and Pharmaceutical. 8. 216. 10.5958/0974-360X.2018.00561.9.
14.Kumar E and Patra CN: Development characterization optimization of ethosome containing duloxetine for transdermal delivery. Int J Pharm Sci & Res 2020; 11(2): 652-59. doi: 10.13040/IJPSR.0975-8232.11(2).652-59